Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NC › RALEIGH › WAKEMED

WAKEMED

NPI: 1972579837 · RALEIGH, NC 27610 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 02/28/2006

$140.71M
Total Medicaid Paid
1,484,819
Total Claims
1,346,937
Beneficiaries
266
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialSESSOMS, STEPHANIE (EXECUTIVE VP, FINANCE & CFO)
Parent OrganizationWAKEMED
NPI Enumeration Date02/28/2006

Related Entities

Other providers sharing the same authorized official: SESSOMS, STEPHANIE

ProviderCityStateTotal Paid
WAKEMED CARY NC $4.12M
WAKEMED RALEIGH NC $14K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 195,121 $13.67M
2019 186,369 $13.55M
2020 126,674 $10.28M
2021 201,268 $19.96M
2022 229,576 $28.97M
2023 242,541 $26.30M
2024 303,270 $27.99M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99284 Emergency department visit for the evaluation and management, high severity 183,814 169,605 $65.57M
99283 Emergency department visit for the evaluation and management, moderate severity 166,859 155,699 $29.72M
99282 Emergency department visit for the evaluation and management, low to moderate severity 64,003 60,325 $6.22M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 30,056 27,723 $5.43M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 13,751 11,901 $5.26M
0240U 24,168 22,177 $3.99M
41899 Unlisted procedure, dentoalveolar structures 2,146 2,030 $2.38M
G0378 Hospital observation service, per hour 10,550 6,556 $2.01M
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 47,265 42,535 $1.73M
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 44,005 39,047 $1.54M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 15,850 14,295 $1.37M
71046 Radiologic examination, chest; 2 views 24,954 23,249 $1.35M
85025 Blood count; complete (CBC), automated, and automated differential WBC count 140,848 126,467 $1.25M
80053 Comprehensive metabolic panel 82,201 73,570 $905K
74177 Computed tomography, abdomen and pelvis; with contrast material 1,413 1,316 $787K
96375 Therapeutic injection; each additional sequential IV push 15,010 12,923 $768K
90460 Immunization administration through 18 years of age via any route, first or only component 7,064 6,489 $578K
96110 Developmental screening, with scoring and documentation, per standardized instrument 7,325 6,816 $544K
87631 5,287 5,163 $459K
84703 48,551 44,023 $457K
90461 5,224 4,884 $428K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 18,899 17,501 $367K
54161 431 400 $353K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8,842 8,216 $332K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 9,316 8,606 $287K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 9,318 8,606 $283K
70450 Computed tomography, head or brain; without contrast material 1,505 1,391 $277K
81001 64,920 59,479 $255K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 8,442 7,858 $243K
87086 Culture, bacterial; quantitative colony count, urine 22,426 20,956 $237K
83690 27,918 25,222 $216K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 5,352 5,036 $210K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,877 4,139 $209K
76705 Ultrasound, abdominal, real time with image documentation; limited 1,405 1,330 $201K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 6,474 5,902 $182K
80048 Basic metabolic panel (calcium, ionized) 19,098 16,874 $180K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7,552 7,109 $178K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,756 2,677 $165K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,548 2,345 $162K
84484 9,865 8,538 $136K
74176 Computed tomography, abdomen and pelvis; without contrast material 385 348 $133K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 810 704 $132K
J7030 Infusion, normal saline solution , 1000 cc 29,818 26,172 $129K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 5,089 4,188 $124K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 4,406 4,040 $123K
84443 Thyroid stimulating hormone (TSH) 6,590 6,107 $111K
87430 7,069 6,760 $111K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 4,792 4,078 $110K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 2,563 2,272 $96K
80061 Lipid panel 5,194 4,924 $94K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,744 2,437 $92K
81003 33,665 30,630 $92K
85027 10,782 9,843 $84K
0202U Oncology (prostate), multianalyte, gene expression profiling 1,493 1,323 $80K
71260 Computed tomography, thorax, diagnostic; with contrast material 352 336 $73K
36415 Collection of venous blood by venipuncture 24,641 21,587 $69K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 4,297 3,881 $65K
86780 3,907 3,549 $64K
76801 636 605 $63K
83036 Hemoglobin; glycosylated (A1C) 4,869 4,576 $62K
76830 Ultrasound, transvaginal 700 661 $62K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 139 102 $56K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 675 648 $55K
83525 3,149 2,981 $53K
71045 Radiologic examination, chest; single view 1,221 1,144 $48K
87081 6,151 5,915 $47K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 467 395 $44K
86885 6,099 5,659 $42K
J2704 Injection, propofol, 10 mg 4,167 3,736 $38K
72125 Computed tomography, cervical spine; without contrast material 199 189 $38K
83735 6,097 5,244 $37K
90472 Immunization administration, each additional vaccine (list separately) 948 833 $36K
84439 3,181 3,014 $36K
31720 768 721 $34K
76770 338 323 $32K
74018 704 671 $32K
96127 2,656 2,553 $29K
86900 6,683 6,206 $27K
86901 6,663 6,186 $24K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 353 210 $22K
J3490 Unclassified drugs 4,547 2,562 $21K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 769 649 $21K
84702 1,958 1,691 $20K
J1885 Injection, ketorolac tromethamine, per 15 mg 7,060 6,457 $20K
96376 671 497 $20K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 485 458 $19K
83516 597 589 $19K
96361 Intravenous infusion, hydration; each additional hour 205 163 $19K
J7120 Ringers lactate infusion, up to 1000 cc 4,814 4,266 $19K
90480 379 329 $18K
83880 689 641 $17K
73630 384 369 $16K
82947 2,758 2,116 $15K
59025 Fetal non-stress test 484 402 $15K
97161 291 280 $14K
77072 394 389 $14K
90834 Psychotherapy, 45 minutes with patient 243 163 $13K
0071A 198 192 $13K
80074 258 232 $13K
82607 824 757 $13K
88305 Level IV - Surgical pathology, gross and microscopic examination 198 164 $13K
73610 290 277 $13K
86140 1,821 1,618 $12K
74019 202 182 $12K
83655 580 540 $12K
73564 374 350 $12K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 204 194 $11K
90832 Psychotherapy, 30 minutes with patient 336 215 $11K
77067 Screening mammography, bilateral, including computer-aided detection 217 207 $11K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 38 35 $10K
J0696 Injection, ceftriaxone sodium, per 250 mg 854 788 $10K
76642 167 150 $10K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 263 238 $9K
87210 1,873 1,771 $8K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 344 303 $8K
80076 1,012 938 $8K
87040 553 515 $8K
87077 948 902 $8K
87150 210 195 $8K
82784 624 611 $8K
90791 Psychiatric diagnostic evaluation 54 52 $7K
J2060 Injection, lorazepam, 2 mg 2,193 1,230 $7K
0081A 105 97 $7K
85610 1,824 1,514 $7K
86762 335 294 $6K
87186 675 637 $6K
86787 351 305 $6K
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring 23 14 $6K
70486 31 28 $6K
73130 156 141 $5K
85651 1,283 1,181 $5K
73030 130 116 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,634 5,953 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 4,967 4,631 $5K
87340 408 374 $5K
99201 323 304 $4K
97802 204 201 $4K
82728 296 281 $4K
86803 242 222 $4K
96380 123 123 $4K
84450 1,507 1,341 $4K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 161 134 $4K
97803 261 247 $4K
D1206 Topical application of fluoride varnish 292 267 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 123 77 $4K
73110 113 108 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 14 14 $4K
86777 188 163 $3K
94664 238 238 $3K
96113 28 25 $3K
0124A 45 42 $3K
J2550 Injection, promethazine hcl, up to 50 mg 324 284 $3K
82570 518 485 $3K
85379 324 305 $3K
82746 204 194 $3K
J3010 Injection, fentanyl citrate, 0.1 mg 4,281 3,664 $3K
85014 639 606 $3K
85018 639 606 $3K
85652 558 505 $2K
83020 143 120 $2K
96112 28 25 $2K
86592 528 510 $2K
82565 460 364 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,414 878 $2K
A0427 Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) 18 12 $2K
0053A 29 29 $2K
J2270 Injection, morphine sulfate, up to 10 mg 1,185 953 $2K
J1630 Injection, haloperidol, up to 5 mg 1,650 799 $2K
72110 28 27 $2K
82105 88 72 $2K
12011 32 26 $2K
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme 1,400 1,243 $2K
86255 119 115 $2K
86038 154 151 $2K
90677 2,160 2,094 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 768 649 $2K
0154A 25 25 $2K
83021 73 70 $2K
10060 30 26 $2K
J7999 Compounded drug, not otherwise classified 731 681 $1K
90847 Family psychotherapy with the patient present, 50 minutes 32 29 $1K
90715 81 77 $1K
84460 1,522 1,354 $1K
85730 300 287 $1K
0001A 21 20 $1K
29125 30 28 $1K
99281 Emergency department visit for the evaluation and management, self-limited or minor 33 30 $1K
96160 159 149 $1K
82950 242 219 $1K
J0134 Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg 174 146 $1K
97530 Therapeutic activities, direct patient contact, each 15 minutes 23 12 $949.65
S0020 Injection, bupivicaine hydrochloride, 30 ml 1,165 1,062 $945.39
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 922 822 $936.07
90837 Psychotherapy, 53 minutes with patient 18 13 $915.30
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 42 41 $874.35
82247 154 95 $869.46
82164 82 80 $852.64
83550 87 80 $844.84
0173A 12 12 $835.60
J7050 Infusion, normal saline solution, 250 cc 426 242 $832.98
83540 115 108 $828.87
90656 1,279 1,267 $828.02
84550 524 482 $805.43
J1050 Injection, medroxyprogesterone acetate, 1 mg 12 12 $800.84
84165 94 93 $774.41
0082A 13 13 $739.94
73080 17 16 $731.50
83605 94 87 $715.51
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 1,277 1,125 $696.67
73140 24 24 $664.51
J2250 Injection, midazolam hydrochloride, per 1 mg 507 450 $664.00
J7510 Prednisolone oral, per 5 mg 296 284 $663.00
80164 47 37 $638.76
96381 16 16 $580.00
J2765 Injection, metoclopramide hcl, up to 10 mg 318 292 $489.47
85660 73 70 $475.00
82248 168 145 $457.58
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 13 13 $440.80
84436 102 101 $434.84
G0109 Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes 26 24 $434.32
83520 24 24 $403.25
84132 106 96 $389.94
82043 55 55 $368.23
86431 89 88 $368.16
87147 57 56 $367.65
90686 2,747 2,295 $367.28
86308 69 63 $354.75
90381 89 89 $341.66
83615 171 152 $331.77
J0290 Injection, ampicillin sodium, 500 mg 50 40 $328.58
90647 2,418 2,328 $311.52
J0171 Injection, adrenalin, epinephrine, 0.1 mg 13 12 $310.23
82550 49 42 $309.94
83002 13 13 $300.04
83001 13 13 $287.92
84153 28 28 $256.20
90723 2,669 2,588 $246.33
S0028 Injection, famotidine, 20 mg 317 295 $236.83
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 550 468 $221.10
81025 25 24 $220.31
90681 841 836 $183.04
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg 59 51 $170.42
90633 572 534 $160.30
90670 1,130 1,098 $145.99
J0780 Injection, prochlorperazine, up to 10 mg 14 12 $109.20
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 143 132 $105.04
80178 12 12 $101.45
84100 30 24 $98.13
J0690 Injection, cefazolin sodium, 500 mg 52 41 $72.64
85045 15 14 $64.87
86364 13 12 $55.08
C9399 Unclassified drugs or biologicals 79 55 $39.99
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 18 12 $38.90
84155 12 12 $4.57
90710 53 50 $0.00
G1010 Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program 94 85 $0.00
90700 58 58 $0.00
91321 215 184 $0.00
90707 89 87 $0.00
90680 1,153 1,085 $0.00
90619 46 41 $0.00
90716 86 84 $0.00
90620 37 36 $0.00
90651 113 108 $0.00
90696 39 39 $0.00
91315 13 13 $0.00